Beneficial effects of endogenous and exogenous melatonin on neural reconstruction and functional recovery in an animal model of spinal cord injury

Journal of Pineal Research

Volumn 52, Issue 1, 2012, Pages 107-119

  Park, Sookyoung ^a   Lee, Sang Kil ^a   Park, Kanghui ^a   Lee, Youngjeon ^a   Hong, Yunkyung ^a   Lee, Seunghoon ^a   Jeon, Je Cheol ^b   Kim, Joo Heon ^b   Lee, Sang Rae ^c   Chang, Kyu Tae ^c   Hong, Yonggeun ^a,c  

^a Inje University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

atrogenes; autophagy; endogenous and exogenous melatonin; functional recovery; glial fibrillary acidic protein; inducible nitric oxide synthase; spinal cord injury

Indexed keywords

ATROGIN 1; BECLIN 1; GLIAL FIBRILLARY ACIDIC PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LC3 II PROTEIN; MELATONIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CONTUSION; CONVALESCENCE; GENE EXPRESSION; HINDLIMB; LOCOMOTION; MALE; MOTOR PERFORMANCE; MUSCLE ATROPHY; NEURAL RECONSTRUCTION; NEUROPROTECTION; NEUROSURGERY; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPINAL CORD INJURY;

ANALYSIS OF VARIANCE; ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; BODY WEIGHT; DISEASE MODELS, ANIMAL; MALE; MELATONIN; MOTOR ACTIVITY; MUSCLE PROTEINS; MUSCULAR ATROPHY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; SKP CULLIN F-BOX PROTEIN LIGASES; SPINAL CORD; SPINAL CORD INJURIES; UBIQUITIN-PROTEIN LIGASES;

EID: 83555173235     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00925.x     Document Type: Article

References (41)

1. Samantaray S, Sribnick EA, Das A, et al., Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res 2008; 44: 348-357. (Pubitemid 351545738)
2. Ray SK, Banik NL,. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord 2003; 2: 173-189.
3. Diaz-Ruiz A, Ibarra A, Perez-Severiano F, et al., Constitutive and inducible nitric oxide synthase activities after spinal cord contusion in rats. Neurosci Lett 2002; 319: 129-132. (Pubitemid 34143189)
4. Hausmann ON,. Post-traumatic inflammation following spinal cord injury. Spinal Cord 2003; 41: 369-378. (Pubitemid 36819586)
5. Park K, Lee Y, Park S, et al., Synergistic effect of melatonin on exercise-induced neuronal reconstruction and functional recovery in a spinal cord injury animal model. J Pineal Res 2010; 48: 270-281.
6. Emirandetti A, Simoes GF, Zanon RG, et al., Spinal motoneuron synaptic plasticity after axotomy in the absence of inducible nitric oxide synthase. J Neuroinflammation 2010; 7: 31.
7. Kwak EK, Kim JW, Kang KS, et al., The role of inducible nitric oxide synthase following spinal cord injury in rat. J Korean Med Sci 2005; 20: 663-669.
8. Hamada Y, Ikata T, Katoh S, et al., Roles of nitric oxide in compression injury of rat spinal cord. Free Radic Biol Med 1996; 20: 1-9. (Pubitemid 26014315)
9. Matsuyama Y, Sato K, Kamiya M, et al., Nitric oxide: a possible etiologic factor in spinal cord cavitation. J Spinal Disord 1998; 11: 248-252. (Pubitemid 28278173)
10. Messing A, Brenner M,. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia 2003; 43: 87-90. (Pubitemid 36781701)
11. Romero-Sandoval A, Chai N, Nutile-Mcmenemy N, et al., A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res 2008; 1219: 116-126.
12. Garrison CJ, Dougherty PM, Kajander KC, et al., Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991; 565: 1-7.
13. Zeman RJ, Zhao J, Zhang Y, et al., Differential skeletal muscle gene expression after upper or lower motor neuron transection. Pflugers Arch 2009; 458: 525-535.
14. Jagoe RT, Goldberg AL,. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr Opin Clin Nutr Metab Care 2001; 4: 183-190. (Pubitemid 33682075)
15. Bodine SC, Latres E, Baumhueter S, et al., Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294: 1704-1708. (Pubitemid 33104839)
16. Gomes MD, Lecker SH, Jagoe RT, et al., Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci U S A 2001; 98: 14440-14445. (Pubitemid 33121410)
17. Wray CJ, Mammen JM, Hershko DD, et al., Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol 2003; 35: 698-705. (Pubitemid 36369517)
18. Li YP, Chen Y, John J, et al., TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 2005; 19: 362-370. (Pubitemid 40316524)
19. Tobimatsu K, Noguchi T, Hosooka T, et al., Overexpression of the transcriptional coregulator Cited2 protects against glucocorticoid-induced atrophy of C2C12 myotubes. Biochem Biophys Res Commun 2009; 378: 399-403.
20. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
21. Huang Z, Liu T, Borjigin J,. N-terminal residues regulate proteasomal degradation of AANAT. J Pineal Res 2010; 48: 290-296.
22. Stehle JH, Saade A, Rawashdeh O, et al., A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
23. Reiter RJ, Tan DX, Sanchez-Barcelor E, et al., Circadian mechanisms in the regulation of melatonin synthesis: disruption with light at night and the pathphysiological consequences. J Exp Integr Med 2011; 1: 13-22.
24. Mcarthur AJ, Gillette MU, Prosser RA,. Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res 1991; 565: 158-161.
25. Tan DX, Chen LD, Poeggeler B, et al., Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
26. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitichondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
27. Rodriguez C, Mayo JC, Sainz RM, et al., Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
28. Erten SF, Kocak A, Ozdemir I, et al., Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord 2003; 41: 533-538. (Pubitemid 37260326)
29. Samantaray S, Das A, Thakore NP, et al., Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res 2009; 47: 134-142.
30. Hong Y, Palaksha KJ, Park K, et al., Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury. J Pineal Res 2010; 49: 201-209.
31. Zhao J, Brault JJ, Schild A, et al., FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 2007; 6: 472-483. (Pubitemid 350163056)
32. Wideman CH, Murphy HM,. Constant light induces alterations in melatonin levels, food intake, feed efficiency, visceral adiposity, and circadian rhythms in rats. Nutr Neurosci 2009; 12: 233-240.
33. Zawilska JB, Skene DJ, Arendt J,. Physiology and pharmacology of melatonin in relation to biological rhythms. Pharmacol Rep 2009; 61: 383-410.
34. Basso DM, Beattie MS, Bresnahan JC,. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996; 139: 244-256. (Pubitemid 26228093)
35. Basso DM, Beattie MS, Bresnahan JC,. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
36. Esposito E, Genovese T, Caminiti R, et al., Melatonin reduces stress-activated/mitogen-activated protein kinases in spinal cord injury. J Pineal Res 2009; 46: 79-86.
37. Genovese T, Mazzon E, Muia C, et al., Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res 2005; 38: 198-208. (Pubitemid 40396179)
38. Ozbek E, Ilbey YO, Ozbek M, et al., Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. J Endourol 2009; 23: 1165-1173.
39. Leger B, Senese R, Al-Khodairy AW, et al., Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients. Muscle Nerve 2009; 40: 69-78.
40. Stitt TN, Drujan D, Clarke BA, et al., The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14: 395-403. (Pubitemid 38591410)
41. Kanno H, Ozawa H, Sekiguchi A, et al., Spinal cord injury induces upregulation of Beclin 1 and promotes autophagic cell death. Neurobiol Dis 2009; 33: 143-148.